#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15356	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2061	736.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	922	C	871	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27450	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	754.3	0	.	n	.	0	T695C	SNP	695	695	T	1134	1134	C	823	C,T	778,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27450	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	754.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1776	1776	A	892	A	836	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27450	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	754.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2410	2410	C	868	C	824	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27450	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	754.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2484	2484	A	898	A	855	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27450	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	754.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3036	3036	C	866	C,A	812,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27450	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	754.3	0	HET	.	.	.	G495A	.	495	495	G	934	934	G	839	G,A	611,186	.	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1946	folP	852	852	100.0	folP.l15.c30.ctg.1	1561	124.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1016	1018	AGC	187;189;190	A;G;C	179;178;180	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5248	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3450	151.5	1	SNP	p	S91F	0	.	.	271	273	TCC	605	607	TCC	182;183;183	T;C;C	170;171;173	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5248	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3450	151.5	1	SNP	p	D95G	0	.	.	283	285	GAC	617	619	GAC	180;179;177	G,T;A;C	169,1;171;166	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5248	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3450	151.5	1	SNP	p	D95N	0	.	.	283	285	GAC	617	619	GAC	180;179;177	G,T;A;C	169,1;171;166	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1369	122.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	414	416	ACC	183;183;183	A;C;C	162;173;175	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1369	122.9	0	.	p	.	0	R44H	NONSYN	130	132	CGC	429	431	CAC	185;183;182	C;A;C	171;168;170	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1369	122.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	612	614	CAC	221;220;221	C;A;C	209;202;209	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1369	122.9	1	SNP	p	G45D	0	.	.	133	135	GGC	432	434	GGC	183;187;189	G;G;C	171;174;178	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	912	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1051	86.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3131	167.9	1	SNP	p	D86N	0	.	.	256	258	GAC	659	661	GAC	245;246;250	G;A;C	230;225;234	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3131	167.9	1	SNP	p	S87W	0	.	.	259	261	AGT	662	664	AGT	250;248;251	A;G;T	233;233;234	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3131	167.9	1	SNP	p	S87R	0	.	.	259	261	AGT	662	664	AGT	250;248;251	A;G;T	233;233;234	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3131	167.9	1	SNP	p	S87I	0	.	.	259	261	AGT	662	664	AGT	250;248;251	A;G;T	233;233;234	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3131	167.9	1	SNP	p	S88P	0	.	.	262	264	TCC	665	667	TCC	251;248;250	T;C,T;C	234;231,1;234	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4372	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2777	156.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1561	1563	GGC	220;221;219	G;G;C	209;208;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1270	1272	GCA	213;215;213	G;C,T;A,G	199;203,1;204,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1273	1275	ATC	215;213;215	A;T;C	205;202;204	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1285	1287	GTG	209;208;210	G;T;G	201;197;200	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1285	1287	GTG	209;208;210	G;T;G	201;197;200	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1789	1791	ACC	217;216;219	A;C;C,T	197;199;203,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1843	1845	GCG	195;193;192	G;C;G	177;164;170	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1843	1845	GCG	195;193;192	G;C;G	177;164;170	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1966	1968	GGC	154;151;148	G;G;C	147;144;141	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1975	1977	GGC	145;144;146	G;G;C	133;133;133	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2483	165.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1993	1995	CCG	127;132;131	C,CG;C;G	91,2;97;90	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5992	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3111	191.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2338	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1906	121.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	620	620	C	180	C	166	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	104	93.27	porB1a.l15.c30.ctg.1	477	33.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	229	231	ACG	80;78;75	A;C;G	72;69;69	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	104	93.27	porB1a.l15.c30.ctg.1	477	33.0	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	271	273	CAA	24;24;21	C;A;A	23;23;20	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	104	93.27	porB1a.l15.c30.ctg.1	477	33.0	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	277	279	TAC	12;10;10	T;A;C	11;9;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	A251V	NONSYN	751	753	GCG	74	76	GTA	30;30;30	G;T;A	25;25;25	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	S271T	NONSYN	811	813	TCG	134	136	ACT	53;53;52	A;C;T	49;50;50	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	140	142	GAT	46;46;44	G;A;T	42;44;41	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	D276N	NONSYN	826	828	GAT	149	151	AAC	45;45;45	A;A;C	42;41;43	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	N277H	NONSYN	829	831	AAC	152	154	CAC	45;45;45	C;A;C	43;44;44	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	242	244	GAA	14;14;14	G;A;A	13;13;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	254	256	GCA	14;14;14	G;C;A	14;14;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	E312D	NONSYN	934	936	GAA	257	259	GAC	14;14;14	G;A;C	13;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	F314T	NONSYN	940	942	TTC	263	265	ACC	13;14;14	A;C;C	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	269	271	TCG	15;14;14	T;C;G	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	275	277	GCC	15;15;15	G;C;C	14;14;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	278	280	AGC	15;14;14	A;G;C	12;13;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	281	283	GCC	13;13;13	G;C;C	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	294	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	444	23.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	287	289	GTT	13;13;12	G;T;T	10;13;11	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2598	porB1b	1041	1041	99.04	porB1b.l15.c30.ctg.1	1443	177.5	0	.	p	.	0	S36Y	NONSYN	106	108	TCT	318	320	TAT	187;187;189	T;A,C;T	178;176,1;175	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2598	porB1b	1041	1041	99.04	porB1b.l15.c30.ctg.1	1443	177.5	0	.	p	.	0	K120D	NONSYN	358	360	AAG	570	572	GAC	200;201;202	G,C;A;C	192,1;194;195	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2598	porB1b	1041	1041	99.04	porB1b.l15.c30.ctg.1	1443	177.5	0	.	p	.	0	K208del	DEL	622	622	A	833	833	A	223	A	216	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2598	porB1b	1041	1041	99.04	porB1b.l15.c30.ctg.1	1443	177.5	0	.	p	.	0	G211S	NONSYN	631	633	GGC	840	842	AGC	209;206;206	A;G;C	205;199;200	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2598	porB1b	1041	1041	99.04	porB1b.l15.c30.ctg.1	1443	177.5	0	.	p	.	0	S216I	NONSYN	646	648	AGC	855	857	ATC	212;211;211	A;T;C	204;203;202	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2598	porB1b	1041	1041	99.04	porB1b.l15.c30.ctg.1	1443	177.5	0	.	p	.	0	I333T	NONSYN	997	999	ATC	1206	1208	ACC	216;214;213	A;C;C	204;205;203	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10256	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	5047	202.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1164	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1143	101.1	1	SNP	p	V57M	1	.	.	169	171	ATG	585	587	ATG	237;236;233	A;T;G	224;223;222	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
